协同的视网膜UCHL1失调和突触脆弱性反映了阿尔茨海默氏病的严重程度
bioRxiv : the preprint server for biology
|February 12, 2026
概括
这就是阿尔茨海默病的原因.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 病理学 病理学 病理学
背景情况:
- 突触功能障碍是阿尔茨海默病 (AD) 的标志,但它的视网膜表现不明.
- 视网膜作为一个潜在的窗口进入中枢神经系统 (CNS) 病理在AD.
研究的目的:
- 通过AD进展来研究人类视网膜中突触退化的分子机制和程度.
- 为了确定潜在的视网膜生物标志物用于AD严重程度和认知衰退.
主要方法:
- 综合基因病理学,超结构分析,蛋白质组学和从正常认知,MCI和AD痴呆症患者的死后视网膜的生物化学概况.
- 利用多变量机器学习模型来识别预测生物标志物.
主要成果:
- 在视网膜中表现出早期,渐进的激发性谷氨酸突触损失,包括VGLUT1,synaptophysin,PSD95和NMDAR2A.
- 发现与粉胺-β 42 (Aβ42) 积累相关的视网膜突触损失,tau病理,氧化应激和p75神经质受体 (p75NTR) 上调.
- 鉴定出失调的乌比奎丁C终端酶L1 (UCHL1) 作为AD布拉克阶段和认知状态的强大视网膜预测剂.
结论:
- 视网膜突触退化是阿尔茨海默病的早期特征,与Aβ/p75NTR通路和UCHL1失调有关.
- 视网膜中的UCHL1不平衡代表了一个潜在的机械枢纽,也是AD严重程度的有希望的生物标志物.
相关概念视频
Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Alzheimer Disease ll: Pathophysiology
44
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
44
Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34


